{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-016063","form_type":"8-K","ticker":"PYXS","cik":"0001782223","company_name":"Pyxis Oncology, Inc.","filed_at":"2022-08-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.015179+00:00","generated_at":"2026-06-24T02:13:46.236386+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"medium","headline":"Pyxis Oncology appoints Jitendra Wadhane as Chief Accounting Officer","bullets":["Mr. Wadhane appointed CAO and Principal Accounting Officer effective August 3, 2022.","He previously served as SVP of Finance and Corporate Controller since August 2021.","Prior roles include Head of SEC Reporting at Immunovant and Senior Manager at EY.","He is a CPA with a Bachelor's from University of Mumbai and Chartered Accountancy from ICAI.","No family relationships or arrangements with other directors or officers."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-016063","json":"https://secwatch.observer/filing/0000950170-22-016063.json","markdown":"https://secwatch.observer/filing/0000950170-22-016063.md","text":"https://secwatch.observer/filing/0000950170-22-016063.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1782223/000095017022016063/0000950170-22-016063-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1782223/000095017022016063/pyxs-20220803.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T02:13:46.236386+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"eecc3a3836","claim":"Jitendra Wadhane was appointed as Chief Accounting Officer at Pyxis Oncology, Inc..","evidence_excerpt":"On August 3, 2022, Jitendra Wadhane, age 42, was appointed as Chief Accounting Officer and to serve as Principal Accounting Officer of Pyxis Oncology, Inc. (the “Company”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1782223/000095017022016063/0000950170-22-016063-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Accounting Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}